RELAPSED/REFRACTORY LYMPHOMAS

Clinical trials for RELAPSED/REFRACTORY LYMPHOMAS explained in plain language.

Never miss a new study

Get alerted when new RELAPSED/REFRACTORY LYMPHOMAS trials appear

Sign up with your email to follow new studies for RELAPSED/REFRACTORY LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill tested for Tough-to-Treat cancers

Disease control Recruiting now

This early-stage study is testing a new oral medication called REC-1245 for people with advanced cancers that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and check for early signs that it might help shr…

Matched conditions: RELAPSED/REFRACTORY LYMPHOMAS

Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

RELAPSED/REFRACTORY LYMPHOMAS

Get alerted when new RELAPSED/REFRACTORY LYMPHOMAS trials appear

New pill tested for Tough-to-Treat cancers